NEW YORK, Oct. 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
TechNavio's analysts forecast the Global Drug-eluting Stents market to reach US$6,278 million by 2015. One of the key factors contributing to this market growth is the increasing incidence of cardiovascular diseases. The Global Drug-eluting Stents market has also been witnessing the use of bifurcated self-expanding coronary stents. However, the decline in the average selling price of drug-eluting stents could pose a challenge to the growth of this market.
TechNavio's report, the Global Drug-eluting Stents Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the key leading countries and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Abbott Laboratories, Boston Scientific Corp., Johnson and Johnson, Medtronic Inc., MicroPort Scientific Corp., and Terumo Medical Corp.
Other vendors mentioned in the report: Allvivo Vascular Inc., Arterial Remodeling Technologies, Bayer MaterialScience, Biocompatibles Ltd., Biosensors International Ltd., Biotronik KG, Blue Medical, Cardiomind, Cook Medical Inc., Devax Inc., Endovasc Inc., Goodman Co. Ltd., InnoCore Technologies BV, Invatec, Lepu Medical Technology, MIV Therapeutics Inc., PolyBioMed, Reva Medical Inc., Stentys SA, SurModics Inc., Translumina GmbH, X-Cell Medical Inc. and Xtent Inc.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
01. Executive Summary
03. Market Coverage
04. Market Landscape
04.1 Overview of the Global Coronary Stents Market
04.2 Global DES Market Size and Forecast
Market Size in Revenue
Market Size in Volume
04.3 DES Market in the US
04.4 DES Market in Germany
04.5 DES Market in Japan
04.6 DES Market in China
04.7 ASP of DES
04.8 Average Number of Stents Used per Patient
04.9 Types of Drugs Used in DES
Drugs Used in DES as Anti-neoplastics
Drugs Used in DES as Immunosupressives
Drugs Used in DES as Migration Inhibitors
Drugs Used in DES as EHFs
Top-selling Drugs used in DES
04.10 Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
Economic Indicators of Key Leading Countries
07. Rate of Incidence and Prevalence
08. Vendor Landscape
08.1 Global DES Market by Vendor Segmentation
08.2 DES Market in the US by Vendor Segmentation
08.3 DES Market in Germany
08.4 DES Market in Japan
08.5 DES Market in China
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1 Abbott Laboratories
15.2 Boston Scientific Corp.
15.3 Johnson and Johnson
15.4 Medtronic Inc.
15.5 Terumo Medical Corp.
15.6 MicroPort Scientific Corp.
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Coronary Stents Market 2011 and 2015 (US$ million)
Exhibit 2: Global Drug-eluting Stents Market 2011-2015 (US$ million)
Exhibit 3: Global Drug-eluting Stents Market 2011-2015 (units in thousands)
Exhibit 4: Drug-eluting Stents Market in the US 2011-2015 (US$ million)
Exhibit 5: Drug-eluting Stents Market in Germany 2011-2015 (US$ million)
Exhibit 6: Drug-eluting Stents Market in Japan 2011-2015 (US$ million)
Exhibit 7: Drug-eluting Stents Market in China 2011-2015 (US$ million)
Exhibit 8: Average Selling Price of Drug-eluting Stents 2011-2015 (US$)
Exhibit 9: Average Number of Stents Used per Patient 2011-2015 (units)
Exhibit 10: Global Drug-eluting Stents Market by Geographical Segmentation 2011 and 2015
Exhibit 11: Incidence Rates of Percutaneous Transluminal Coronary Angioplasty and Stenting Procedures in Key Leading Countries 2011
Exhibit 12: Global Drug-eluting Stents Market by Vendor Segmentation 2011
Exhibit 13: Drug-eluting Stents Market in the US by Vendor Segmentation 2011
Exhibit 14: Drug-eluting Stents Market in Germany by Vendor Segmentation 2011
Exhibit 15: Drug-eluting Stents Market in Japan by Vendor Segmentation 2011
Exhibit 16: Drug-eluting Stents Market in China by Vendor Segmentation 2011
Exhibit 17: Global Coronary Stents Market 2011 (percentage)
Exhibit 18: Global Coronary Stents Market 2015 (percentage)
Exhibit 19: Business Segmentation of Abbott Laboratories
Exhibit 20: Business Segmentation of Cordis Corp.
Exhibit 21: Business Segmentation of Medtronic Inc.
Exhibit 22: Business Segmentation of Terumo Medical Corp.
To order this report:
Contact Nicolas: firstname.lastname@example.org
Intl: +1 805-652-2626